MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,773.95
+0.66%
NASDAQ 100
$31,076.44
+0.87%
DOW JONES
$51,268.00
+0.18%
NASDAQ Composite
$27,477.31
+1.05%
RUSSELL 2000
$2,833.80
+0.66%
CBOE VIX
$15.52
+1.37%
Sector Heatmap
Technology+0.56%
Financials+0.73%
Healthcare+0.72%
Consumer Cycl+0.35%
Consumer Staples+0.63%
Energy+0.99%
Industrials+0.09%
Materials+1.31%
Real Estate-0.34%
Utilities+0.35%
Comm Services+1.17%
LNSR — LENSAR, Inc. Common Stock
NasdaqLENSAR, Inc. Common Stock
$6.67
-0.08(-1.19%)
- O
- 6.73
- H
- 6.85
- L
- 6.67
- V
- 51.53K
⏱️ End-of-day dataAs of Oct 5, 2026
Chart
About LNSR
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
SectorNot available
IPO DateSep 21, 2020
Employees150
Stock ExchangeNasdaq
Ticker SymbolLNSR
Websitehttps://www.lensar.com
Key Financial Statistics
| Market Cap | $82.93M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $4.95 - $12.94 |
| 52-Week Avg Volume | 86.0K |
| VWAP | $6.74 |
| Transactions | 703 |
| Total Recorded Bars | 1,508 days |